← Open Payments lookup

JEFFREY KEZLARIAN: Open Payments

NPI 1548351075 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,221 in 41 payments from 10 companies in 2025. Trend: 2023 $1,561 · 2024 $1,308 · 2025 $1,221

Food & beverage: $1,220Education: $1
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.10$310
Axsome Therapeutics, Inc.6$235
Neurocrine BioSciences, Inc.5$226
E.R. Squibb & Sons, L.L.C.6$194
Validus Pharmaceuticals LLC5$80
Collegium Pharmaceutical, Inc.3$61
Otsuka America Pharmaceutical, Inc.2$37
ABBVIE INC.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Teva Pharmaceuticals USA, Inc.1$22

Products named: FANAPT, Auvelity, INGREZZA, COBENFY, EQUETRO, Jornay PM, VRAYLAR, CAPLYTA.

Industry payments across MI — which companies pay providers there.